JPWO2023068377A5 - - Google Patents
Info
- Publication number
- JPWO2023068377A5 JPWO2023068377A5 JP2023554769A JP2023554769A JPWO2023068377A5 JP WO2023068377 A5 JPWO2023068377 A5 JP WO2023068377A5 JP 2023554769 A JP2023554769 A JP 2023554769A JP 2023554769 A JP2023554769 A JP 2023554769A JP WO2023068377 A5 JPWO2023068377 A5 JP WO2023068377A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- set forth
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021172760 | 2021-10-22 | ||
| JP2022020022 | 2022-02-11 | ||
| PCT/JP2022/039419 WO2023068377A1 (ja) | 2021-10-22 | 2022-10-22 | ＳＡＲＳ－ＣｏＶ－２のＯＲＦ８タンパク質に結合するモノクローナル抗体及び該抗体を含む炎症抑制組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023068377A1 JPWO2023068377A1 (https=) | 2023-04-27 |
| JPWO2023068377A5 true JPWO2023068377A5 (https=) | 2025-11-27 |
Family
ID=86058337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554769A Pending JPWO2023068377A1 (https=) | 2021-10-22 | 2022-10-22 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023068377A1 (https=) |
| WO (1) | WO2023068377A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119464223B (zh) * | 2025-01-07 | 2025-04-04 | 中山大学 | 分泌抗新型冠状病毒orf8蛋白单克隆抗体的杂交瘤细胞株、单克隆抗体、抗体组合物和应用 |
-
2022
- 2022-10-22 JP JP2023554769A patent/JPWO2023068377A1/ja active Pending
- 2022-10-22 WO PCT/JP2022/039419 patent/WO2023068377A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9938347B2 (en) | Tumor necrosis factor (TNF) superfamily receptor IgM antibodies and uses thereof | |
| AU767580B2 (en) | Single-chain multiple antigen binding molecule, its preparation and use | |
| JP2025036561A5 (https=) | ||
| JP2022105138A5 (https=) | ||
| JP2025032102A5 (https=) | ||
| CN107532188A (zh) | Cd20结合分子及其用途 | |
| TW201111394A (en) | Bispecific, tetravalent antigen binding proteins | |
| JP2010539921A5 (https=) | ||
| JP2020505919A5 (https=) | ||
| JP2005510246A5 (https=) | ||
| JPWO2019209995A5 (https=) | ||
| JPWO2021097376A5 (https=) | ||
| JP2025038088A5 (https=) | ||
| WO2020211674A1 (zh) | 抗FXI/FXIa抗体及其用途 | |
| JP2018514193A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2018508218A5 (https=) | ||
| JPWO2023068377A5 (https=) | ||
| JPWO2021081365A5 (https=) | ||
| JPWO2022094299A5 (https=) | ||
| JPWO2020216697A5 (https=) | ||
| JPWO2020172605A5 (https=) | ||
| JPWO2021007260A5 (https=) | ||
| JPWO2022114163A5 (https=) | ||
| JPWO2021224913A5 (https=) |